INT353062

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.13
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 3
Disease Relevance 5.03
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endoplasmic reticulum (HSD11B1, ADIPOQ) generation of precursor metabolites and energy (ADIPOQ) extracellular space (ADIPOQ)
extracellular region (ADIPOQ) small molecule metabolic process (HSD11B1) oxidoreductase activity (HSD11B1)
HSD11B1 (Homo sapiens)
ADIPOQ (Homo sapiens)
Pain Link Frequency Relevance Heat
antidepressant 9 15.28 Low Low
depression 33 14.24 Low Low
Endocannabinoid 24 5.00 Very Low Very Low Very Low
Multiple sclerosis 9 5.00 Very Low Very Low Very Low
Central nervous system 6 5.00 Very Low Very Low Very Low
antagonist 6 5.00 Very Low Very Low Very Low
Cannabinoid 6 5.00 Very Low Very Low Very Low
fluoxetine 3 5.00 Very Low Very Low Very Low
alcohol 3 5.00 Very Low Very Low Very Low
Neuropeptide 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disorder Of Lipid Metabolism 72 100.00 Very High Very High Very High
Overweight 78 97.68 Very High Very High Very High
Obesity 150 97.12 Very High Very High Very High
Insulin Resistance 48 96.12 Very High Very High Very High
Weight Loss 165 90.24 High High
Diabetes Mellitus 132 88.48 High High
Clinical Trials And Case Reports 33 83.60 Quite High
Metabolic Syndrome 381 75.32 Quite High
Pressure And Volume Under Development 36 69.08 Quite High
Depression 33 14.24 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Furthermore, other cardiovascular risk factors improved during rimonabant treatment, including increased HDL-C and adiponectin, and reduced TG, LDL:HDL and total:HDL-C ratios, and leptin and C-reactive protein levels.
HDL Regulation (improved) of Gene_expression (levels) of adiponectin associated with disorder of lipid metabolism
1) Confidence 0.13 Published 2007 Journal Core Evidence Section Body Doc Link PMC3012438 Disease Relevance 1.68 Pain Relevance 0
Furthermore, other cardiovascular risk factors improved during rimonabant treatment, including increased HDL-C and adiponectin, and reduced TG, LDL:HDL and total:HDL-C ratios, and leptin and C-reactive protein levels.
HDL Regulation (improved) of Gene_expression (levels) of adiponectin associated with disorder of lipid metabolism
2) Confidence 0.13 Published 2007 Journal Core Evidence Section Body Doc Link PMC3012438 Disease Relevance 1.68 Pain Relevance 0
Furthermore, other cardiovascular risk factors improved during rimonabant treatment, including increased HDL-C and adiponectin, and reduced TG, LDL:HDL and total:HDL-C ratios, and leptin and C-reactive protein levels.
HDL Regulation (improved) of Gene_expression (levels) of adiponectin associated with disorder of lipid metabolism
3) Confidence 0.13 Published 2007 Journal Core Evidence Section Body Doc Link PMC3012438 Disease Relevance 1.68 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox